Cytokinetics (CYTK) PT Raised to $60 at Oppenheimer
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $75.87 +2.35%
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Join SI Premium – FREE
Oppenheimer analyst Justin Kim raised the price target on Cytokinetics (NASDAQ: CYTK) to $60.00 (from $57.00) while maintaining a Outperform rating.
You May Also Be Interested In
- H.C. Wainwright Reiterates Buy Rating on Cytokinetics (CYTK)
- Rakus Co Ltd (3923:JP) PT Raised to JPY1,300 at Macquarie
- Cytokinetics (CYTK) PT Raised to $110 at Barclays
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
